Status:
RECRUITING
Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients
Lead Sponsor:
University Institute of Maia
Collaborating Sponsors:
Aveiro University
Centro Hospitalar de Vila Nova de Gaia/Espinho
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
One of the recommended treatments for breast cancer is neoadjuvant chemotherapy (NCT), however, only 20% of the patients subject to this therapy present pathologic complete response (pCR). If exercise...
Eligibility Criteria
Inclusion
- being female gender;
- age equals or greater than 18 years old;
- having a newly diagnosed histologically confirmed breast carcinoma IA-IIIC;
- planned to receive neoadjuvant chemotherapy with anthracyclines or taxanes, that might be associated to anti-HER2 drugs;
- being followed by the oncology department of the CHVNG/E;
- medical oncologists consents the practice of physical exercise;
- the patient is capable of providing written informed consent;
- the participant accepts to be allocated to the control or experimental group, according to the randomization.
Exclusion
- previous cancer diagnostic;
- evidence of synchronous oncologic disease;
- physical or psychiatric contraindication to the practice of physical exercise.
Key Trial Info
Start Date :
July 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT05976815
Start Date
July 31 2023
End Date
August 1 2026
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Hospitalar Vila Nova Gaia e Espinho
Vila Nova de Gaia, Porto District, Portugal, 4434-502